About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Encapsulated Sclerosing Peritonitis Successfully Treated with Corticosteroid Therapy and Total Parental Nutrition
Anam Hanut1, Rola Nakhoul2, Michael Jerdev3, Roth Ana1, Farid Nakhoul1,4, Evgeny Farber1
1Nephrology & Hypertension Division and 3Department of Radiology, Baruch Padeh Poriya Medical Center, Tiberias, Israel; 2Szeged Faculty of Medicine, Szeged, Hungary; 4Azrieli Faculty of Medicine, Ramat Gan, Israel.
Corresponding Author:
Dr. Evgeny Farber
Email: Efarber@poria.health.gov.il
Received: 08-MAY-2017 Accepted: 05-JUL-2018 Published Online: 25-JUL-2018
DOI: http://dx.doi.org/10.17659/01.2018.0048
Background: The number of patients with end stage renal disease (ESRD) who need renal replacement therapy to survive is increasing worldwide. Continuous ambulatory peritoneal dialysis (CAPD) is the preferred treatment to treat ESRD in an increasing number of patients. However, the long-term effectiveness of CAPD is limited by complications such as peritonitis. Encapsulating sclerosing peritonitis (ESP), a rare cause of bowel obstruction with high morbidity and mortality, was described as a complication associated with peritoneal dialysis. Case Report: Here we report a case where early abdominal CT in association with clinical symptoms allowed non-invasive diagnosis of ESP, and immediate steroid treatment successfully relieved the symptoms with excellent outcome. Conclusion: Early diagnosis and institution of corticosteroid therapy is effective treatment of encapsulating sclerosing peritonitis secondary to peritoneal dialysis.
Keywords : Peritoneal Dialysis, Peritoneal Fibrosis, Intestinal Obstruction, Ultrasonography, Computed Tomography.
Article Options
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share